ANRS 12372 MODERATO Study

Condition:   HIV-1-infection Interventions:   Drug: dolutegravir;   Drug: atazanavir boosted with ritonavir;   Drug: tenofovir + lamivudine +efavirenz;   Drug: Lamivudine Sponsors:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS);   Mylan Laboratories Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials